FDA Says Novo's Wegovy, Injection, .25 mg/.5 ml (NDC 0169-4525-14) Under Limited Availability With Estimated Shortage Duration TBD; Wegovy, Injection, .5 mg/.5 ml (NDC 0169-4505-14) Under Limited Availability With Estimated Shortage Duration TBD; ...
Novo Nordisk A/S Sponsored ADR Class B -0.73%
Novo Nordisk A/S Sponsored ADR Class B NVO | 116.47 | -0.73% |
- Reuters